These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 24885672)

  • 1. Comparison of conventional medicine, TCM treatment, and combination of both conventional medicine and TCM treatment for patients with chronic obstructive pulmonary disease: study protocol of a randomized comparative effectiveness research trial.
    Li JS; Xie Y; Li SY; Yu XQ
    Trials; 2014 May; 15():153. PubMed ID: 24885672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effective evaluation on symptoms and quality of life of chronic obstructive pulmonary disease patients treated by comprehensive therapy based on traditional Chinese medicine patterns.
    Li JS; Li SY; Xie Y; Yu XQ; Wang MH; Sun ZK; Ma LJ; Jia XH; Zhang HL; Xu JP; Hou CX
    Complement Ther Med; 2013 Dec; 21(6):595-602. PubMed ID: 24280466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bu-Fei Yi-Shen granule combined with acupoint sticking therapy in patients with stable chronic obstructive pulmonary disease: a randomized, double-blind, double-dummy, active-controlled, 4-center study.
    Li JS; Li SY; Yu XQ; Xie Y; Wang MH; Li ZG; Zhang NZ; Shao SJ; Zhang YJ; Zhu L; Guo LX; Bai YP; Wang YF
    J Ethnopharmacol; 2012 Jun; 141(2):584-91. PubMed ID: 21911051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of comprehensive therapy based on traditional Chinese medicine patterns in stable chronic obstructive pulmonary disease: a four-center, open-label, randomized, controlled study.
    Li SY; Li JS; Wang MH; Xie Y; Yu XQ; Sun ZK; Ma LJ; Zhang W; Zhang HL; Cao F; Pan YC
    BMC Complement Altern Med; 2012 Oct; 12():197. PubMed ID: 23107470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of beclomethasone/formoterol fixed combination on lung hyperinflation and dyspnea in COPD patients.
    Tzani P; Crisafulli E; Nicolini G; Aiello M; Chetta A; Clini EM; Olivieri D
    Int J Chron Obstruct Pulmon Dis; 2011; 6():503-9. PubMed ID: 22069361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Budesonide/formoterol maintenance and reliever therapy in Asian patients (aged ≥16 years) with asthma: a sub-analysis of the COSMOS study.
    Vogelmeier C; Naya I; Ekelund J
    Clin Drug Investig; 2012 Jul; 32(7):439-49. PubMed ID: 22607479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the Chinese herbal formula San-Huang Gu-Ben Zhi-Ke treatment on stable chronic obstructive pulmonary disease: study protocol of a randomized, double-blind, placebo-controlled trial.
    Zu Y; Li D; Lei X; Zhang H
    Trials; 2019 Nov; 20(1):647. PubMed ID: 31775843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Traditional Chinese medicine in the treatment of idiopathic pulmonary fibrosis based on syndrome differentiation: Study protocol of an exploratory trial.
    Yu XQ; Yang SG; Xie Y; Li JS
    J Integr Med; 2020 Mar; 18(2):163-168. PubMed ID: 31928920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluticasone/formoterol combination therapy is as effective as fluticasone/salmeterol in the treatment of asthma, but has a more rapid onset of action: an open-label, randomized study.
    Bodzenta-Lukaszyk A; Dymek A; McAulay K; Mansikka H
    BMC Pulm Med; 2011 May; 11():28. PubMed ID: 21605396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study to assess COPD Symptom-based Management and to Optimise treatment Strategy in Japan (COSMOS-J) based on GOLD 2011.
    Betsuyaku T; Kato M; Fujimoto K; Hagan G; Kobayashi A; Hitosugi H; James M; Jones PW
    Int J Chron Obstruct Pulmon Dis; 2013; 8():453-9. PubMed ID: 24124358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness and healthcare budget impact in Italy of inhaled corticosteroids and bronchodilators for severe and very severe COPD patients.
    Dal NR; Eandi M; Pradelli L; Iannazzo S
    Int J Chron Obstruct Pulmon Dis; 2007; 2(2):169-76. PubMed ID: 18044689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost effectiveness of budesonide/formoterol for maintenance and reliever therapy versus salmeterol/fluticasone plus salbutamol in the treatment of asthma.
    Johansson G; Andreasson EB; Larsson PE; Vogelmeier CF
    Pharmacoeconomics; 2006; 24(7):695-708. PubMed ID: 16802845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of traditional Chinese medicine on outcomes in patients with mild/moderate chronic obstructive pulmonary disease: study protocol for a randomized placebo-controlled trial.
    Wang M; Li J; Li S; Wang H; Yu X; Zhang H
    Trials; 2012 Jul; 13():109. PubMed ID: 22799753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effectiveness of budesonide/formoterol and fluticasone/salmeterol for COPD management.
    Roberts M; Mapel D; Petersen H; Blanchette C; Ramachandran S
    J Med Econ; 2011; 14(6):769-76. PubMed ID: 21942463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of budesonide/formoterol and fluticasone/salmeterol combinations in COPD patients: findings from a real-world analysis in an Italian setting.
    Perrone V; Sangiorgi D; Buda S; Degli Esposti L
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2749-2755. PubMed ID: 27853362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment comparison of budesonide/formoterol with salmeterol/fluticasone propionate in adults aged > or =16 years with asthma: post hoc analysis of a randomized, double-blind study.
    Kuna P
    Clin Drug Investig; 2010; 30(9):565-79. PubMed ID: 20593912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of combination salmeterol (50 microg)/fluticasone propionate (500 microg) inhalation twice daily via accuhaler in Chinese patients with COPD.
    Zheng JP; Yang L; Wu YM; Chen P; Wen ZG; Huang WJ; Shi Y; Wang CZ; Huang SG; Sun TY; Wang GF; Xiong SD; Zhong NS
    Chest; 2007 Dec; 132(6):1756-63. PubMed ID: 17951625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined corticosteroid and longacting beta-agonist in one inhaler for chronic obstructive pulmonary disease.
    Nannini L; Lasserson TJ; Poole P
    Cochrane Database Syst Rev; 2003; (4):CD003794. PubMed ID: 14583994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluticasone propionate/formoterol for COPD management: a randomized controlled trial.
    Papi A; Dokic D; Tzimas W; Mészáros I; Olech-Cudzik A; Koroknai Z; McAulay K; Mersmann S; Dalvi PS; Overend T
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1961-1971. PubMed ID: 28740376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of combination fluticasone propionate-salmeterol 250/50 microg versus salmeterol in severe COPD patients.
    Dalal AA; St Charles M; Petersen HV; Roberts MH; Blanchette CM; Manavi-Zieverink K
    Int J Chron Obstruct Pulmon Dis; 2010 Aug; 5():179-87. PubMed ID: 20714371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.